Cancer Health Treatment Update Cancer Patients and Transplant Recipients Need Both COVID-19 Vaccines Doses Natural immunity and vaccine responses may be weaker in people with immune suppression, so they should get their second dose promptly. FDA Approves Fotivda for Advanced Kidney Cancer The kinase inhibitor delayed disease progression by 27% for people who had tried at least two prior therapies. How One Molecule Involved in Most Leukemias May Lead to Targeted Therapies Researchers have identified another molecule that may lead to the development of more effective targeted medications.  Financial Toxicity Increases Cancer Death Risk People with head and neck cancer who are worried about the cost of treatment are about twice as likely to die as people who are not. Advertisement For COVID ‘Long Haulers,’ Battling for Disability Benefits As people with long COVID pursue the disability application process, they are discovering a particular set of challenges. More News About COVID-19 For more news about the novel coronavirus and COVID-19, including how it affects people living with cancer, visit our sister site, COVID Health.com. Cancer Health Spring 2021 Check out our latest print edition! Newsfeed Four Ways the $1.9 Trillion COVID-19 Relief Plan Boosts Obamacare Trump’s ‘Chinese Virus’ Tweet Linked to Rise of Anti-Asian Hashtags on Twitter Jamie Foxx Encourages At-Risk Minorities to Get Screened for Colorectal Cancer Financial Toxicity Increases Cancer Death Risk Blog: Food and Drug Administration (FDA) FDA Approves Yescarta for Follicular Lymphoma FDA Approves Lorbrena for Metastatic ALK-Positive Lung Cancer FDA Approved Pepaxto for Heavily Treated Multiple Myeloma FDA Approves Drug to Reduce Bone Marrow Suppression Caused by Chemotherapy Newsfeed Four Ways the $1.9 Trillion COVID-19 Relief Plan Boosts Obamacare Trump’s ‘Chinese Virus’ Tweet Linked to Rise of Anti-Asian Hashtags on Twitter Jamie Foxx Encourages At-Risk Minorities to Get Screened for Colorectal Cancer Financial Toxicity Increases Cancer Death Risk Blog: Food and Drug Administration (FDA) FDA Approves Yescarta for Follicular Lymphoma FDA Approves Lorbrena for Metastatic ALK-Positive Lung Cancer FDA Approved Pepaxto for Heavily Treated Multiple Myeloma FDA Approves Drug to Reduce Bone Marrow Suppression Caused by Chemotherapy

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: